Search research articles
Contact Us
Filters
Showing results (1-10 of 181) with videos related to
Page
of 19
Sort By:
Breast (Edinburgh, Scotland)
|
June 1, 2010
Hypofractionated breast radiotherapy: financial and economic consequences
Yolande Lievens
The Lancet. Oncology
|
February 1, 2024
Modelling radiotherapy availability in the Asia-Pacific region
Yolande Lievens
Acta Oncologica (Stockholm, Sweden)
|
August 24, 2017
Access to innovative radiotherapy: how to make it happen from an economic perspective?
Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 14, 2012
Health economics in radiation oncology: introducing the ESTRO HERO project
Yolande Lievens, Cai Grau
Frontiers in Medicine
|
December 3, 2019
Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?
Mathieu Spaas, Yolande Lievens
Revue Medicale De Liege
|
May 23, 2024
[Health-economic aspects of radiotherapy]
Miet Vandemaele, Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 28, 2017
Adjuvant breast radiotherapy: How to trade-off cost and effectiveness?
Chris Monten, Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2018
Economic data for particle therapy: Dealing with different needs in a heterogeneous landscape
Yolande Lievens, Klaus Nagels
Translational Lung Cancer Research
|
August 25, 2021
Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
Nora Sundahl, Yolande Lievens
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Radiotherapy cost-calculation and its impact on capacity planning
Yolande Lievens, Berend Jan Slotman
Page
of 19
Search research articles
Search
Showing results (1-10 of 181) with videos related to
Sort By:
Page
of 19
Breast (Edinburgh, Scotland)
|
June 1, 2010
Hypofractionated breast radiotherapy: financial and economic consequences
Yolande Lievens
The Lancet. Oncology
|
February 1, 2024
Modelling radiotherapy availability in the Asia-Pacific region
Yolande Lievens
Acta Oncologica (Stockholm, Sweden)
|
August 24, 2017
Access to innovative radiotherapy: how to make it happen from an economic perspective?
Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 14, 2012
Health economics in radiation oncology: introducing the ESTRO HERO project
Yolande Lievens, Cai Grau
Frontiers in Medicine
|
December 3, 2019
Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?
Mathieu Spaas, Yolande Lievens
Revue Medicale De Liege
|
May 23, 2024
[Health-economic aspects of radiotherapy]
Miet Vandemaele, Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 28, 2017
Adjuvant breast radiotherapy: How to trade-off cost and effectiveness?
Chris Monten, Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2018
Economic data for particle therapy: Dealing with different needs in a heterogeneous landscape
Yolande Lievens, Klaus Nagels
Translational Lung Cancer Research
|
August 25, 2021
Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
Nora Sundahl, Yolande Lievens
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Radiotherapy cost-calculation and its impact on capacity planning
Yolande Lievens, Berend Jan Slotman
Page
of 19